Post-earnings recap
Reported
Thu, Oct 23, 2008
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Thermo Fisher Scientific's earnings report shows a significant miss on EPS, which likely contributed to the stock's decline of 6.39%. Investors may be concerned about the company's performance, especially since no revenue figures or guidance updates were provided. The lack of management commentary leaves uncertainty regarding future expectations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.50 | N/A | -34.30% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.